Connection

Allen Kaplan to Binding, Competitive

This is a "connection" page, showing publications Allen Kaplan has written about Binding, Competitive.
Connection Strength

0.225
  1. Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5. Int Immunopharmacol. 2002 Dec; 2(13-14):1875-85.
    View in: PubMed
    Score: 0.051
  2. Effect of neurotropin on the binding of high molecular weight kininogen and Hageman factor to human umbilical vein endothelial cells and the autoactivation of bound Hageman factor. Biochem Pharmacol. 1998 Apr 15; 55(8):1175-80.
    View in: PubMed
    Score: 0.037
  3. Binding of activation of kinin-forming proteins on vascular endothelial cells. Immunopharmacology. 1997 Jun; 36(2-3):201-7.
    View in: PubMed
    Score: 0.035
  4. Further characterization of histamine releasing chemokines present in fractionated supernatants derived from human mononuclear cells. Clin Exp Allergy. 1996 Aug; 26(8):926-33.
    View in: PubMed
    Score: 0.033
  5. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. J Biol Chem. 1993 Jun 05; 268(16):11982-7.
    View in: PubMed
    Score: 0.026
  6. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med. 1992 Feb 01; 175(2):489-93.
    View in: PubMed
    Score: 0.024
  7. Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity. Blood. 1989 Aug 01; 74(2):695-702.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.